Advanced Heart Failure (HF) is a complex and challenging condition that often requires advanced treatment options, such as heart transplantation or long-term Left Ventricular Assist Devices (LVADs). These interventions can significantly improve the quality of life and survival of patients with end-stage HF. However, they also come with unique considerations and challenges that must be carefully addressed to ensure optimal outcomes. This article explores the particular aspects that healthcare providers should take into account when considering heart transplantation and long-term LVAD therapy for patients with advanced HF. Immunosuppression: Following transplantation, patients require lifelong immunosuppressive therapy to prevent organ rejection. Managing immunosuppression is challenging due to the risk of infections, malignancies, and medication side effects.
HTML PDFShare this article
Transplantation Technologies & Research received 223 citations as per Google Scholar report
